- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02042963
KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) (KNOW-KT)
KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation : A 9-year Longitudinal Cohort Study of the Kidney Transplantation (KNOW-KT)
KNOW-KT (KoreaN cohort study for Outcome in patients With KT: A 9-year Longitudinal cohort study of the Korean adult KT patients), funded by Korea Center for Disease Control and Prevention (KCDC) was established in 2012 by a group of transplant physicians, transplant surgeons, nephrologists, epidemiologists, and biostatisticians in Korea.
We aimed to establish an adult KT cohort, to investigate the renal allograft outcomes, mortality, complications, and to explore traditional or nontraditional risk factors for morbidity and mortality. We established a bio-bank to integrate clinical and biological information. Here, we report design and method of the KNOW-KT.
Study Overview
Status
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National Univeristy Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Recipients and Donors of kidney transplant
Exclusion Criteria:
- Multi-organ transplant recipients
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
KNOW-KT
1000 Kidney transplant recipients in Korea
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
overall mortality
Time Frame: 9 years
|
9 years
|
|
|
Allograft survival
Time Frame: 9 years
|
defined as re-transplant or initiation of maintenance dialysis
|
9 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life
Time Frame: 2 years
|
2 years
|
|
|
cardiovascular event
Time Frame: 9 years
|
Acute Myocardial Infarction Revascularization : PCI or CABG Stroke Admission from Congestive heart failure
|
9 years
|
|
Albuminuria
Time Frame: 9 years
|
9 years
|
|
|
Acute Rejection
Time Frame: 9 years
|
9 years
|
|
|
New onset of diabetes after transplant
Time Frame: 9 years
|
9 years
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Jung HY, Jeon Y, Huh KH, Park JB, Kim MG, Lee S, Han S, Ro H, Yang J, Ahn C, Cho JH, Park SH, Kim YL, Kim CD. Pretransplant and Posttransplant Alcohol Consumption and Outcomes in Kidney Transplantation: A Prospective Multicenter Cohort Study. Transpl Int. 2022 May 30;35:10243. doi: 10.3389/ti.2022.10243. eCollection 2022.
- Hong N, Lee J, Kim HW, Jeong JJ, Huh KH, Rhee Y. Machine Learning-Derived Integer-Based Score and Prediction of Tertiary Hyperparathyroidism among Kidney Transplant Recipients: An Integer-Based Score to Predict Tertiary Hyperparathyroidism. Clin J Am Soc Nephrol. 2022 Jul;17(7):1026-1035. doi: 10.2215/CJN.15921221. Epub 2022 Jun 10.
- Yang J, Lee J, Huh KH, Park JB, Cho JH, Lee S, Ro H, Han SY, Kim YH, Jeong JC, Park BJ, Han DJ, Park SB, Chung W, Park SK, Kim CD, Kim SJ, Kim YS, Ahn C; KNOW-KT Study Group. KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodology. BMC Nephrol. 2014 May 9;15:77. doi: 10.1186/1471-2369-15-77.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KNOW-KT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Transplant Recipients
-
University of CincinnatiUniversity of Colorado, Denver; Children's Hospital Medical Center, CincinnatiCompletedLiver Transplant Recipients | Kidney Transplant RecipientsUnited States
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Clinical Trials in Organ TransplantationCompletedKidney Transplant Recipients | Living-Donor Kidney TransplantUnited States
-
National Institute of Allergy and Infectious Diseases...Genomics of Transplantation Cooperative Research ProgramCompletedKidney Transplant Donor | KidneyTransplant Recipients | Simultaneous Kidney/Pancreas RecipientsUnited States, Canada
-
Angus W. Thomson PhD DScNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingKidney Transplant | Renal Transplant RecipientsUnited States
-
Astellas Pharma China, Inc.Terminated
-
Astellas Pharma China, Inc.CompletedKidney Transplant RecipientsChina
-
Mayo ClinicVeloxis PharmaceuticalsCompletedKidney Transplant RecipientsUnited States
-
Dokuz Eylul UniversityCompletedKidney Transplant RecipientsTurkey
-
National Institute of Diabetes and Digestive and...CompletedKidney Transplant Recipients
-
University of CincinnatiNovartis PharmaceuticalsCompletedKidney Transplant RecipientsUnited States